Request for Applications Now Open for New Stand Up To Cancer-Cancer Research UK Translational Research FellowshipFour grants for up to $315,000 each available; application deadline is July 28, 2014
April 7, 2014 – PHILADELPHIA — The American Association for Cancer Research (AACR) is now accepting applications for the Stand Up To Cancer (SU2C)-Cancer Research UK Translational Research Fellowship, which will provide up to four grants for postdoctoral or clinical research fellows, each up to $315,000, over a four-year period. This grant opportunity is provided by SU2C and Cancer Research UK and is the first joint research project resulting from the collaboration between the two groups announced in 2012.
The transatlantic partnership between SU2C and Cancer Research UK has been made possible by the launch of SU2C in the United Kingdom in 2012. This is a joint national fundraising initiative between Cancer Research UK and the U.K. broadcaster Channel 4 to help accelerate groundbreaking research.
The SU2C-Cancer Research UK Translational Research Fellowship will provide four years of research fellowship support to talented and promising early-career investigators in the United States and the United Kingdom who demonstrate clear potential to become leaders in their fields. Research projects must be translational in nature and address critical problems in cancer with the potential to deliver benefit to patients.
The proposed work must be performed in two phases, one in the United States and one in the United Kingdom. Each phase must be one to three years in length, and the total support period for this fellowship is a maximum of four years. Applications must identify one mentor and qualified host laboratory in the United States and one mentor and qualified host laboratory in the United Kingdom. Mentors should be established leaders in cancer research with a track record of successful mentoring. The research proposal must describe how the work has the potential to advance to the clinic.
Since the launch of SU2C in 2008, the AACR has played an integral role as SU2C’s Scientific Partner, providing scientific leadership, expert peer review, and grants administration. To that end, the AACR will work closely with Cancer Research UK on this project. A SU2C-Cancer Research UK Joint Scientific Advisory Committee will conduct an interactive, rapid, and rigorous evaluation of the applications via a multistep scientific review process, and will recommend final grant recipients. Lee J. Helman, M.D., and Richard M. Marais, Ph.D., F.Med.Sci., will co-chair the committee. Helman is scientific director for clinical research and head of the Molecular Oncology Section at the National Cancer Institute Center for Cancer Research. Marais is director of the Cancer Research UK Manchester Institute, where he also heads the Molecular Oncology Group.
• Project proposals for the SU2C-Cancer Research UK Translational Research Fellowship are due by noon ET July 28, 2014, via proposalCENTRAL at https://proposalcentral.altum.com.
• For general information on eligibility criteria, the application process, and other details about this grant, visit http://www.AACR.org/SU2Cfunding. Inquiries may be directed to the AACR Scientific Review and Grants Administration Department at 267-765-1049 or email@example.com.
The SU2C-Cancer Research UK Translational Research Fellowship recipients are scheduled to be announced in the fall of 2014.
# # #Media Contacts:
Cancer Research UK
About Stand Up To Cancer
Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry’s resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about progress being made in the fight against the disease. As SU2C’s scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, Ph.D., conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.
Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. All current members of the CFA were co-producers of the 2012 televised special. The late co-founder Laura Ziskin executive produced both the Sept. 5, 2008, and Sept. 10, 2010, broadcasts. SU2C was formally launched on May 27, 2008. Sung Poblete, Ph.D., R.N., has served as SU2C’s president and CEO since 2011.
For more information on Stand Up To Cancer visit http://www.standup2cancer.org.
About Stand Up To Cancer UK
• SU2C was launched in the UK in 2012 as a joint initiative between Cancer Research UK and Channel 4 to help accelerate ground breaking cancer research.
• To date the UK fundraising campaign has raised over £8 million, making it the most successful charity fundraiser on UK commercial TV in its first year.
• Since then, Cancer Research UK and Channel 4 have confirmed a 5-year partnership, which will see Stand Up To Cancer back on UK screens until 2018.
• Visit Standuptocancer.org.uk or channel4.co.uk/SU2C for further information.
About Cancer Research UK
Cancer Research UK’s vision, to “bring forward the day when all cancers are cured,” is a statement of what the Charity aspires to, why it exists, and describes the impact the Charity would like to have on society. Cancer Research UK has four main purposes, each of which describes what they will do to achieve our vision:
• To carry out world-class research to improve our understanding of cancer and find out how to prevent, diagnose and treat different kinds of cancer;
• To ensure that our findings are used to improve the lives of all cancer patients;
• To help people to understand cancer, the progress we are making and the choices each person can make;
• To work in partnership with others to achieve the greatest impact in the global fight against cancer.
• For further information about Cancer Research UK’s work or to find out how to support the charity, please call 0300 123 1022 or visit http://www.cancerresearchuk.org. Follow us on Twitter and Facebook.
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit http://www.AACR.org. Follow the AACR on Twitter: @AACR. Follow the AACR on Facebook: https://www.facebook.com/aacr.org.